Supernus Pharmaceuticals | SUPN - Capital Ordinário





Capital Ordinário Alterar Data
Abbott USD 1.74B 23.39B 2025-09
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Cara Therapeutics USD 2K 3K 2025-03
Corcept Therapeutics USD 105.97M 842K 2025-12
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Novo Nordisk DKK 4.44B 0 2025-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
United Therapeutics USD 43.64M 740K 2025-12
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12